Applied Protein Sciences

Applied Protein Sciences is a company.

Active

Updated: Mar 20, 2026 ·

About

Applied Protein Biotechnologies engineers high-performance proteins, enzymes, and biocatalysts, also offering complete reaction systems. The company employs advanced rational and non-rational protein engineering to create enhanced enzyme variants. Its portfolio includes molecular biology kits, mass spectrometry reagents, and specialized industrial enzymes, delivering innovative biological solutions for chemical synthesis and biocatalysis applications.

Established around 2019, Applied Protein Biotechnologies originated from a group of scientists and entrepreneurs. Their core insight involved leveraging advanced evolved enzymes, underpinned by proprietary intellectual property, to address specific market demands. This foundation allowed them to apply sophisticated protein engineering, forming a strong basis for product development across biochemical and industrial sectors.

Applied Protein Biotechnologies serves the laboratory research reagents, industrial enzymes, chemical, and health and wellness markets. The company’s vision is to foster a technology-driven future through intelligent biotechnological solutions. Its mission focuses on providing commercially relevant proteins and innovative products, supporting diverse enterprises, including traditional industries, with adaptable biological engineering.

Financial History

Total Raised

N/A

Valuation

N/A

Financial History

Total Raised

N/A

Valuation

N/A

Leadership Team

Key people at Applied Protein Sciences.

Aman Johar

Co-founder/CEO

Leadership Team

Key people at Applied Protein Sciences.

Aman Johar

Co-founder/CEO

Deep Dive

Applied Protein Sciences was a biotechnology company specializing in the development of novel protein-based products using proprietary protein engineering platforms. It designed highly stable and functional proteins for applications across therapeutics, diagnostics, and industrial processes, improving protein properties such as solubility, activity, and immunogenicity. The company served pharmaceutical and biotech sectors by providing advanced protein solutions to address challenges in drug development and diagnostics. Applied Protein Sciences was eventually acquired by another firm, integrating its technology and products into a broader portfolio[2].

Origin Story

Applied Protein Sciences was co-founded by Aman Johar, whose background is in biotechnology and protein engineering. The idea emerged from the need to create better protein products with enhanced stability and functionality for various applications, including therapeutics and diagnostics. Early traction came from the successful application of their proprietary protein engineering platform, which differentiated them in a competitive biotech landscape focused on protein innovation[2].

Core Differentiators

Proprietary Protein Engineering Platform: Enabled design of proteins with improved solubility, activity, and reduced immunogenicity.
Versatile Applications: Products served multiple sectors including therapeutics, diagnostics, and industrial uses.
Enhanced Protein Stability and Functionality: Addressed common challenges in protein-based product development.
Integration Post-Acquisition: Technology and products became part of a larger firm’s portfolio, expanding reach and resources[2].

Role in the Broader Tech Landscape

Applied Protein Sciences operated within the growing trend of protein engineering and synthetic biology, which are critical for advancing next-generation therapeutics and diagnostics. The timing was favorable due to increasing demand for biologics and precision medicine solutions that require highly tailored protein products. Market forces such as the rise of personalized medicine, biologics manufacturing, and diagnostic innovation supported the company’s growth and relevance. By advancing protein engineering capabilities, Applied Protein Sciences contributed to the broader ecosystem by enabling more effective and scalable protein-based solutions[2].

Quick Take & Future Outlook

Following its acquisition, the core technologies of Applied Protein Sciences are likely to continue influencing the biotech sector through integration into larger platforms, accelerating innovation in protein therapeutics and diagnostics. Trends such as mRNA therapeutics, biologics, and precision diagnostics will shape the ongoing evolution of protein engineering companies. The company’s legacy lies in its pioneering protein design platform, which remains a valuable asset in the expanding protein sciences field[2].

---

Note: Applied Protein Sciences should not be confused with Protein Sciences Corporation, a separate vaccine-focused biotech company acquired by Sanofi in 2017, which develops recombinant influenza vaccines such as Flublok[1][3][7].

Sources

Frequently Asked Questions

Who founded Applied Protein Sciences?

Applied Protein Sciences was founded in 2007 by Aman Johar (Co-founder/CEO).